Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jun 23, 2010

Premium

Pharmacogenomics firm Gentris Corporation announced this week the appointment of Rick Williams as its CEO and a member of the company's board of directors.

Early in his career, Williams served as Genentech's director of marketing and health economics. Additionally, he has held various executive positons at Merck, Amerisource Bergen, and CellzDirect-Invitrogen. He has also worked with non-profit organizations such as The Hammer Institutes and the North Carolina Biotechnology Center.


Genetic Technologies announced this week the appointment of Lewis Stuart as general manager of its newly established North American molecular diagnostics business. The Melbourne, Australia-based firm is launching a diagnostics unit in the US to expand its genetic testing franchise in oncology with the acquisition of the non-hereditary breast cancer test BREVAGen.

Stuart previously served as the senior VP of commercial operations at CV Therapeutics, which was acquired by Gilead in 2009. Prior to CV Therapeutics, Stuart held senior sales and marketing positions at the Pfizer subsidiary Agouron Pharmaceuticals, Bristol Myers Squibb, Solvay Pharmaceuticals, Centocor, and Upjohn.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.